🟢 Edesa Biotech is trading 6.28% up in pre-market with no confirmed catalyst

Edesa Biotech is trading at $5.08 (+6.28%) in pre-market without a confirmed catalyst.

• No new company-specific announcement for September 2, 2026 was identified.
• The latest notable company news remains the $25 million public offering announced August 19–20, but it is stale for this move.
• Broader futures are lower, so market sentiment does not clearly explain the gain; limited early trading activity may be a factor.